The exosomal miR-105 secreted by breast cancer (BC) targets MXI1, activates the MYC pathway in CAFs, enhances the glycolysis and glutamine decomposition of CAFs, and detoxifies the metabolites (lactate and NH4 +) to fuel adjacent cancer cells [238]. Here, MYC is linked to breast cancer.